ARTIFICIAL INTELLIGENCE (AI) IN CHEMICAL MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Artificial Intelligence (AI) in Chemical Market, By Type (Hardware, Software, Services), By Application (Discovery of new materials,Production optimization,Pricing optimization,Load forecasting of raw materials,Product portfolio optimization,Feedstock optimization,Process management & control), By End User (Base Chemicals & Petrochemicals,Specialty Chemicals,Agrochemicals), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Feb 2024
Code : CMI6604
Pages :145
Formats :
Excel and PDF
Industry : Information and Communication Technology

Market News

In January 2023, Bayer entered into a strategic partnership with Google Cloud, which aimed at enhancing the capabilities of Bayer in the realm of quantum chemistry research. This collaboration is designed to pioneer new pathways in drug discovery, utilizing the advanced capabilities of machine learning. Bayer AG is a German multinational pharmaceutical and biotechnology company, one of the largest pharmaceutical companies and biomedical companies in the world. In fiscal 2022, the company employed around 101,000 people and had sales of €50.7 Bn
Bayer is committed to driving sustainable development and generating a positive impact through innovation and growth. The company's brand stands for trust, reliability, and quality throughout the world .
Google Cloud is a suite of cloud computing services offered by GoogleIt provides a range of modular cloud services, including computing, storage, data analytics, machine learning, and more Google Cloud Platform (GCP) runs on the same infrastructure that Google uses internally for its end-user products, such as Google Search, Gmail, and Google Docs
In January 2023, researchers initiated a groundbreaking study leveraging the power of AlphaFold alongside artificial intelligence to accelerate the process of creating novel therapeutics targeting liver cancer.
On January 16, 2023, Chemical.AI publicized their cooperation agreement with NovAliX, a leading global CRO specializing in drug development, thereby signifying a significant step forward in their collaborative efforts.
Chemical.AI is an artificial intelligence company that focuses on developing tools for the chemical and pharmaceutical industries.
In 2022, significant breakthrough when scholars from IIIT-Delhi devised an innovative AI-driven technique purposed for the detection of potentially cancer-causing agents within chemical compounds.
In 2022, Sanofi secured a partnership with Exscientia, marked by a US$100 million investment earmarked for the advancement of 15 new small molecules for the treatment of cancer and immunological disorders, thereby showcasing their dedication to the future of healthcare. Exscientia is a global pharmatech company that uses artificial intelligence (AI) to discover better drugs faster . The company's mission is to encode, automate, and transform every stage of the drug design and development process by combining the latest AI techniques with experimental innovation . Exscientia's validated platform has delivered the first three AI-designed drugs to enter clinical trials.